|
March 16, 2006, Basel, Switzerland
HEC Group signed agreement with Roche on the license of Oseltamivir in China, making HEC the third company in the world permitted by Roche to produce Oseltamivir.
Oseltamivir, marketed by Roche under the brand name Tamiflu, is recommended by scientists worldwide to be one of the most effective treatment against H5N1 strain of Bird Flu.
For more details, please refer to the following news released by Reuters: |
